Showing 16,641 - 16,660 results of 31,172 for search '(( 2 step decrease ) OR ( 50 ((we decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.12s Refine Results
  1. 16641

    Andro induced ROS-dependent autophagy while Taxi attenuated it. by Mazen Alzaharna (3737878)

    Published 2017
    “…<p>Cells were treated as indicated, stained with DCF-DA and then analyzed using the flow cytometer. (A) A representative histograms showing the increase in ROS in HeLa cells treated with Andro (25, 50 or 100 μM) while the decrease in ROS in those treated with Taxi (50, 100 or 200μM) for 24h. …”
  2. 16642

    Inhibition of EGFR-Grb2 interaction by the small tyrosine kinase inhibitor AG1478. by Peter Lanzerstorfer (540769)

    Published 2014
    “…(B) Time course of the Grb2 contrast change upon EGF stimulation in control and AG1478 pretreated (1, 10 μM) cells (n = 50). Pretreatment with a tyrosine kinase inhibitor leads to a decreased contrast compared to untreated cells. …”
  3. 16643

    Autophagic changes in villous explants. by Tai-Ho Hung (306051)

    Published 2013
    “…Scale bar = 20 µm (d, e) Using an antibody with a stronger reactivity to the type II form of LC3B to study the autophagic changes, a decrease in the level of LC3-II was noted in villous explants treated with vitamins C and E at 8% oxygen in comparison to the vehicle control. …”
  4. 16644

    Intense reelin IR neurons synthesize reelin whereas punctate reelin IR neurons are characterized by the presence of receptor-bound reelin. by Cecilia Gonzalez Campo (264260)

    Published 2009
    “…GST-RAP was used at 25, 40 and 50 µg/ml. A significant decrease of punctate reelin IR was observed with 40 and 50 µg/ml of GST-RAP (4.5±1.5% and 3.1±0.7%; n = 3 and 3) whereas no effect was detected with a concentration of 25 µg/ml compared to untreated (22.2±1.4% and 21.3±2.2%; n = 3 and 3; F<sub>(3,8)</sub> = 45.7, ***P<0.001). …”
  5. 16645
  6. 16646

    Exploring <i>in vitro</i> anticancer potential of <i>Ferula gummosa</i> gum on PC-3 cells: insights from cellular and molecular studies by Negar Abdollahzadeh (20507068)

    Published 2025
    “…This resulted in mitochondrial membrane damage and the release of lactate dehydrogenase. Alongside this, we observed a decrease in intracellular ROS levels and a weakening of the mitochondrial membrane potential. …”
  7. 16647

    Comparison between α1β2γ2 and α3β2γ2 GABA-channel currents elicited by brief GABA applications by Andrea Barberis (74413)

    Published 2011
    “…Journal Compilation © Federation of European Neuroscience Societies and Blackwell Publishing Ltd</p> (A) Multiple records of 1 s illustrating channel activity evoked by 2 ms applications of GABA to outside-out patches in two patches excised from human embryonic kidney (HEK) cells expressing single α1β2γ2 (left, 10 m GABA) and α3β2γ2 (right, 50 m GABA) channels (holding potential, −100 mV). …”
  8. 16648

    Image_3_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  9. 16649

    Table_2_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.doc by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  10. 16650

    Image_9_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  11. 16651

    Image_10_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  12. 16652

    Image_2_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  13. 16653

    Image_1_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  14. 16654

    Image_11_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  15. 16655

    Image_7_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  16. 16656

    Image_8_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  17. 16657

    Image_5_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  18. 16658

    Image_6_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  19. 16659

    Image_12_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”
  20. 16660

    Image_13_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg by Rewan Abdelaziz (12961639)

    Published 2023
    “…Background<p>Antimicrobial resistance is a serious threat to public health globally. It is a slower-moving pandemic than COVID-19, so we are fast running out of treatment options.…”